BamSEC and AlphaSense Join Forces
Learn More

Docola, Inc.

Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.12
from S-1/A 21 pages Docola, Inc. Executive Employment Agreement Dated as of November ___, 2023
12/34/56
EX-10.11
from S-1/A 20 pages Docola, Inc. Executive Employment Agreement Dated as of November ___, 2023
12/34/56
EX-10.10
from S-1/A 20 pages Docola, Inc. Executive Employment Agreement Dated as of November ___, 2023
12/34/56
EX-10.7
from S-1/A 2 pages Amendment to Master Services Agreement
12/34/56
EX-10.9
from S-1 11 pages Master Services Agreement
12/34/56
EX-10.8
from S-1 6 pages Collaborative Agreement Sano Genetics and Docola Inc. 1. Definitions
12/34/56
EX-10.7
from S-1 2 pages Amendment to Master Services Agreement
12/34/56
EX-10.6
from S-1 19 pages Certain Confidential Portions of This Exhibit Have Been Omitted and Replaced With “[***]”. Such Identified Information Has Been Excluded From This Exhibit Because It Is (I) Not Material and (II) Would Be Competitively Harmful if Publicly Disclosed. Master Services Agreement
12/34/56
EX-10.5
from S-1 5 pages Memorandum of Understanding Between Docola and Patients for Patient Safety United States
12/34/56
EX-10.4
from S-1 6 pages Nonexclusive License Agreement
12/34/56
EX-10.3
from S-1 9 pages License Agreement
12/34/56
EX-10.2
from S-1 8 pages License Agreement
12/34/56
EX-10.1
from S-1 46 pages Docola, Inc. 2022 Equity Incentive Plan
12/34/56
EX-10.5
from DRS/A 5 pages Memorandum of Understanding Between Docola and Patients for Patient Safety United States
12/34/56
EX-10.9
from DRS 11 pages Master Services Agreement
12/34/56
EX-10.8
from DRS 6 pages Collaborative Agreement Sano Genetics and Docola Inc. 1. Definitions
12/34/56
EX-10.7
from DRS 2 pages Amendment to Master Services Agreement
12/34/56
EX-10.6
from DRS 19 pages Certain Confidential Portions of This Exhibit Have Been Omitted and Replaced With “[***]”. Such Identified Information Has Been Excluded From This Exhibit Because It Is (I) Not Material and (II) Would Be Competitively Harmful if Publicly Disclosed. Master Services Agreement
12/34/56
EX-10.5
from DRS 7 pages Memorandum of Understanding Between Docola and Patients for Patient Safety United States
12/34/56
EX-10.4
from DRS 6 pages Nonexclusive License Agreement
12/34/56